Academia.edu vs Oracle
Side-by-side comparison
| Academia.edu | Oracle | |
|---|---|---|
| Product | Academia Premium | Cerner Enviza |
| Category | Research Discovery | Research Discovery |
| What it does | Unlock advanced analytics and exclusive features to enhance your research impact and audience insights. | Delivering data-driven insights and research services for the life sciences industry. |
| Pricing model | Subscription-based | — |
| Target company size | SMB, Mid-Market, Enterprise | SMB, Mid-Market, Enterprise |
| Deployment | SaaS | SaaS |
| Integrations | — | Salesforce, SAP, Shopify, Snowflake, Workday |
| API available | — | Yes |
| Certifications | — | SOC 2, GDPR, HIPAA |
About Academia Premium
Academia Premium is a subscription service offered by Academia.edu, designed to provide researchers with advanced tools and insights beyond the free tier. It offers a suite of exclusive features aimed at helping users understand their readership, gain deeper insights from their analytics, and generally improve their experience on the Academia platform. The service focuses on enhancing the researc
Use cases: Learn more about your readers and their demographics., Get more out of your analytics to understand research impact., Improve your overall Academia.edu experience with exclusive features., Enhance the dissemination and visibility of your research papers., Track engagement patterns and geographic distribution of your readership.
Full Academia Premium blueprint · Academia.edu company profile
About Cerner Enviza
Cerner Enviza, a wholly-owned subsidiary of Oracle Corporation, specializes in providing data-driven insights and research services specifically tailored for the life sciences industry. It forms a crucial part of Oracle's broader healthcare offerings, leveraging Oracle's robust cloud infrastructure and technological capabilities to support advancements in medical research and patient care. The pl
Use cases: Accelerating drug discovery and development., Optimizing clinical trial design and execution., Generating real-world evidence for regulatory submissions., Identifying patient cohorts for targeted therapies., Improving post-market surveillance and pharmacovigilance.